Difference between revisions of "Template:Lipid modifying agents"

From blackwiki
Jump to navigation Jump to search
imported>Anypodetos
 
(46 intermediate revisions by 24 users not shown)
Line 1: Line 1:
 
{{Navbox
 
{{Navbox
| name = Lipid modifying agents
+
| name = Lipid modifying agents
| title = [[Hypolipidemic agent|Lipid modifying agents]] ([[ATC code C10|C10]])
+
| title = [[Hypolipidemic agent|Lipid-modifying agents]] ([[ATC code C10|C10]])
| groupstyle = background:MistyRose;
+
| state = {{{state<includeonly>|autocollapse</includeonly>}}}
 +
| listclass = hlist
  
| group1 = [[GI tract]]
+
| group1 = [[Human gastrointestinal tract|GI tract]]
| list1 = {{Navbox subgroup
+
| list1 = {{Navbox|child
| groupstyle = background:MistyRose;
 
  
| group1 = [[Cholesterol absorption inhibitor]]s, [[NPC1L1]]
+
  | group1 = [[Cholesterol absorption inhibitor]]s, [[NPC1L1]]
| list1 = [[Ezetimibe]]&nbsp;•  [[SCH-48461]]
+
  | list1 =
 +
* [[Ezetimibe]]
 +
* [[SCH-48461]]
  
| group2 = [[Bile acid sequestrant]]s/[[Ion exchange resin|resins]] ([[Low-density lipoprotein|LDL]])
+
  | group2 = [[Bile acid sequestrant]]s/[[Ion-exchange resin|resins]] ([[Low-density lipoprotein|LDL]])
| list2 = [[Cholestyramine]]&nbsp;•  [[Colestipol]]&nbsp;•  [[Colestilan]]&nbsp;•  [[Colextran]]&nbsp;•  [[Colesevelam]]
+
  | list2 =
 +
* [[Colesevelam]]
 +
* [[Colestilan]]
 +
* [[Colestipol]]
 +
* [[Colestyramine]]
 +
* [[Colextran]]
  
}}
+
}}
  
 +
| group2 = [[Liver]]
 +
| list2 = {{Navbox|child
  
| group2 = [[Liver]]
+
  | group1 = [[Statin]]s ([[HMG-CoA reductase]], [[Low-density lipoprotein|LDL]])
| list2 = {{Navbox subgroup
+
  | list1 =
| groupstyle = background:MistyRose;
+
* [[Atorvastatin]]
 +
* [[Cerivastatin]]<sup>‡</sup>
 +
* [[Fluvastatin]]
 +
* [[Lovastatin]]
 +
* [[Mevastatin]]
 +
* [[Pitavastatin]]
 +
* [[Pravastatin]]
 +
* [[Rosuvastatin]]
 +
* [[Simvastatin]]<sup>#</sup>
  
| group1 = [[Statin]]s ([[HMG-CoA reductase]], [[Low-density lipoprotein|LDL]])
+
  | group2 = Niacin and derivatives ([[High-density lipoprotein|HDL]] and [[Low-density lipoprotein|LDL]])
| list1  = [[Simvastatin]]<sup>#</sup>&nbsp;•  [[Atorvastatin]]&nbsp;•  [[Fluvastatin]]&nbsp;•  [[Lovastatin]]&nbsp;•  [[Mevastatin]]&nbsp;•  [[Pitavastatin]]&nbsp;•  [[Pravastatin]]&nbsp;•  [[Rosuvastatin]]&nbsp;•  [[Cerivastatin]]<sup>‡</sup>
+
  | list2 =
 +
* [[Acipimox]]
 +
* [[Aluminium nicotinate]]
 +
* [[Niacin]]
 +
* [[Niceritrol]]
 +
* [[Nicofuranose]]
 +
* [[Nicotinyl alcohol]]
  
| group2 = Niacin and derivatives ([[High-density lipoprotein|HDL]] and [[Low-density lipoprotein|LDL]])
+
  | group3 = [[Microsomal triglyceride transfer protein|MTTP]] inhibitors ([[Very low-density lipoprotein|VLDL]])
| list2 = [[Niceritrol]]&nbsp;•  [[Niacin]]&nbsp;•  [[Nicofuranose]]&nbsp;•  [[Aluminium nicotinate]]&nbsp;•  [[Nicotinyl alcohol]]&nbsp;•  [[Acipimox]]
+
  | list3 =
 +
* [[Dirlotapide]]
 +
* [[Lomitapide]]
 +
* [[Mitratapide]]
  
}}
+
  | group4 = [[ATP citrate lyase]] inhibitors ([[Low-density lipoprotein|LDL]])
 +
  | list4 =
 +
* [[Bempedoic acid]]
  
| group4 = [[Blood vessel]]s
+
  }}
| list4 = {{Navbox subgroup
 
| groupstyle = background:MistyRose;
 
  
| group1 =   [[Fibrate]]s ([[PPAR modulator|PPAR]])
+
| group3 = [[Blood vessel]]s
| list1  = [[Clofibrate]]<sup>‡</sup>&nbsp;•  [[Bezafibrate]]&nbsp;•  [[Aluminium clofibrate]]&nbsp;•  [[Gemfibrozil]]&nbsp;•  [[Fenofibrate]]&nbsp;•  [[Simfibrate]]&nbsp;•  [[Ronifibrate]]&nbsp;•  [[Ciprofibrate]]&nbsp;•  [[Etofibrate]]&nbsp;•  [[Clofibride]]&nbsp;•  [[Clinofibrate]]
+
| list3 = {{Navbox|child
 +
  | evenodd = swap
  
 +
  | group1 = [[Fibrate]]s ([[PPAR agonist|PPAR]])
 +
  | list1 =
 +
* [[Aluminium clofibrate]]
 +
* [[Bezafibrate]]
 +
* [[Choline fenofibrate]]
 +
* [[Ciprofibrate]]
 +
* [[Clinofibrate]]
 +
* [[Clofibrate]]<sup>‡</sup>
 +
* [[Clofibride]]
 +
* [[Etofibrate]]
 +
* [[Fenofibrate]]
 +
* [[Gemfibrozil]]
 +
* [[Pemafibrate]]
 +
* [[Ronifibrate]]
 +
* [[Simfibrate]]
  
| group2 = [[CETP inhibitor]]s ([[High-density lipoprotein|HDL]])
+
  | group2 = [[CETP inhibitor]]s ([[High-density lipoprotein|HDL]])
| list2 = [[Anacetrapib]]<sup>†</sup>&nbsp;•  [[Dalcetrapib]]&nbsp;•  [[Torcetrapib]]<sup>§</sup>
+
  | list2 =
 +
* [[Anacetrapib]]<sup>†</sup>
 +
* [[Dalcetrapib]]<sup>§</sup>
 +
* [[Evacetrapib]]<sup>§</sup>
 +
* [[Obicetrapib]]<sup>†</sup>
 +
* [[Torcetrapib]]<sup>§</sup>
  
 +
  | group3 = [[PCSK9 inhibitor]]s ([[Low-density lipoprotein|LDL]])
 +
  | list3 =
 +
* [[Alirocumab]]
 +
* [[Bococizumab]]
 +
* [[Evolocumab]]
  
 +
}}
  
}}
+
| group4 = Combinations
 +
| list4 =
 +
* [[Amlodipine/atorvastatin]]
 +
* [[Bempedoic acid/ezetimibe]]
 +
* [[Ezetimibe/atorvastatin]]
 +
* [[Ezetimibe/rosuvastatin]]
 +
* [[Ezetimibe/simvastatin]]
 +
* [[Fenofibrate/pravastatin]]
 +
* [[Fenofibrate/simvastatin]]
 +
* [[Laropiprant|Niacin/laropiprant]]
 +
* [[Niacin/lovastatin]]
 +
* [[Niacin/simvastatin]]
  
 +
| group5 = Other
 +
| list5 =
 +
* [[Alipogene tiparvovec]]
 +
* [[Azacosterol]]
 +
* [[Azalanstat]]
 +
* [[Benfluorex]]<sup>‡</sup>
 +
* [[Darapladib]]<sup>§</sup>
 +
* [[Dextrothyroxine]]<sup>‡</sup>
 +
* [[Inclisiran]]
 +
* [[Lapaquistat]]<sup>§</sup>
 +
* [[Magnesium pyridoxal 5-phosphate glutamate]]
 +
* [[Meglutol]]
 +
* [[Mipomersen]]
 +
* [[Omega-3-triglycerides]]
 +
* [[Policosanol]]
 +
* [[Probucol]]
 +
* [[Tiadenol]]
 +
* [[Triparanol]]<sup>‡</sup>
 +
* [[Volanesorsen]]
  
| group7 = Combinations
+
  | list6 = {{PharmNavFootnote}}
|  list7 = [[Niacin/lovastatin]]&nbsp;•  [[Niacin/simvastatin]]&nbsp;•  [[Ezetimibe/simvastatin]]&nbsp;• [[Niacin/laropiprant]]
 
 
 
| group8 = Other
 
| list8 = [[Dextrothyroxine]]&nbsp;•  [[Probucol]]&nbsp;•  [[Tiadenol]]&nbsp;•  [[Benfluorex]]&nbsp;•  [[Meglutol]]&nbsp;•  [[Omega-3-triglycerides]]&nbsp;•  [[Magnesium pyridoxal 5-phosphate glutamate]]&nbsp;•  [[Policosanol]]&nbsp;•  [[Lapaquistat]]<sup>§</sup>&nbsp;•  [[Alipogene tiparvovec]]
 
 
 
| list9 = {{PharmNavFootnote}}
 
 
 
| belowstyle = background: transparent; padding: 0px;
 
| below = {{Metabolic navs}}
 
  
 
}}<noinclude>
 
}}<noinclude>
 
+
{{collapsible option}}
[[Category:Drug_templates by ATC|{{PAGENAME}}]]
+
[[Category:Drug templates by ATC]]
[[pt:Predefinição:Hipolipemiantes]]
 
 
</noinclude>
 
</noinclude>

Latest revision as of 14:49, 3 January 2021

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Lipid modifying agents|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Lipid modifying agents|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Lipid modifying agents|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.